Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Neogenomics Inc (NEO) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Neogenomics Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1077183.
Total stock buying since 2015: $2,158,610.
Total stock sales since 2015: $372,603,469.
Total stock option exercises since 2015: $33,923,832.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 113,010 | $797,551 | 0 | $0 | 158,153 | $0 |
| 2024 | 0 | $0 | 13,874 | $215,766 | 252,120 | $0 |
| 2023 | 0 | $0 | 0 | $0 | 1,507 | $17,481 |
| 2022 | 0 | $0 | 3,209 | $58,692 | 16,161 | $123,952 |
| 2021 | 17,000 | $520,710 | 478,521 | $18,765,432 | 349,751 | $5,102,096 |
| 2020 | 0 | $0 | 1,815,127 | $70,726,519 | 1,264,895 | $10,112,498 |
| 2019 | 0 | $0 | 1,913,033 | $42,348,765 | 1,569,627 | $10,691,323 |
| 2018 | 26,000 | $301,600 | 16,536,400 | $221,356,668 | 664,899 | $2,729,275 |
| 2017 | 20,000 | $183,800 | 167,990 | $1,327,287 | 353,331 | $814,919 |
| 2016 | 22,007 | $149,195 | 1,824,807 | $14,689,025 | 2,482,168 | $4,251,876 |
| 2015 | 25,950 | $205,754 | 385,000 | $3,115,315 | 51,218 | $80,412 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-05-03 | Cardoza George (President, Pharma Services) | Sale | 151,676 | 22.82 | 3,461,246 |
| 2019-05-02 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 30,000 | 7.33 | 220,050 |
| 2019-05-02 | Shovlin Robert J. (President, Clinical Services) | Sale | 119,347 | 22.14 | 2,642,342 |
| 2019-05-02 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 133,333 | 7.33 | 977,997 |
| 2019-05-02 | Cardoza George (President, Pharma Services) | Option Ex | 200,000 | 4.78 | 956,000 |
| 2019-03-04 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 14,000 | 19.09 | 267,260 |
| 2019-03-04 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 14,000 | 8.03 | 112,419 |
| 2019-02-28 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 30,000 | 19.57 | 587,100 |
| 2019-02-28 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 30,000 | 7.78 | 233,250 |
| 2019-02-28 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 13,986 | 7.15 | 99,999 |
| 2019-02-27 | Shovlin Robert J. (President, Clinical Services) | Sale | 44,135 | 19.23 | 848,716 |
| 2019-02-27 | Cardoza George (President, Pharma Services) | Option Ex | 30,000 | 3.45 | 103,500 |
| 2019-02-27 | Jones Steven C (Executive Vice President) | Sale | 285,252 | 18.84 | 5,374,147 |
| 2019-02-26 | Shovlin Robert J. (President, Clinical Services) | Sale | 141,879 | 18.88 | 2,678,675 |
| 2019-02-26 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 186,014 | 7.33 | 1,364,412 |
| 2019-02-26 | Jones Steven C (Executive Vice President) | Sale | 14,621 | 19.25 | 281,454 |
| 2019-02-26 | Bonello William (Chief Strategy Officer) | Sale | 60,203 | 18.90 | 1,137,836 |
| 2019-02-26 | Bonello William (Chief Strategy Officer) | Option Ex | 60,203 | 7.78 | 468,078 |
| 2019-02-26 | Hipp Raymond R | Sale | 18,889 | 18.90 | 357,002 |
| 2019-02-26 | Hipp Raymond R | Option Ex | 18,889 | 7.05 | 133,224 |
| 2018-12-21 | Johnson Kevin C | Buy | 26,000 | 11.60 | 301,600 |
| 2018-12-14 | Ge Medical Systems Information Technologies, Inc. (Other) | Sale | 10,835,145 | 12.00 | 130,021,740 |
| 2018-11-19 | Tetrault Lynn A. | Sale | 13,000 | 15.98 | 207,805 |
| 2018-11-15 | Tetrault Lynn A. | Option Ex | 18,888 | 7.68 | 145,059 |
| 2018-11-14 | Tetrault Lynn A. | Sale | 5,000 | 16.16 | 80,800 |
| 2018-11-14 | Jones Steven C (Executive Vice President) | Sale | 5,553 | 16.50 | 91,624 |
| 2018-11-13 | Jones Steven C (Executive Vice President) | Sale | 35,574 | 16.68 | 593,196 |
| 2018-11-12 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 28,505 | 16.73 | 476,888 |
| 2018-11-12 | Shovlin Robert J. (President, Clinical Services) | Sale | 36,493 | 16.76 | 611,622 |
| 2018-11-12 | Jones Steven C (Executive Vice President) | Sale | 100,000 | 16.66 | 1,666,000 |
| 2018-11-09 | Ge Medical Systems Information Technologies, Inc. (10% Owner) | Sale | 4,164,855 | 16.75 | 69,761,321 |
| 2018-11-09 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 39,828 | 17.00 | 677,076 |
| 2018-11-09 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 68,333 | 2.39 | 163,315 |
| 2018-11-09 | Shovlin Robert J. (President, Clinical Services) | Sale | 180,000 | 17.05 | 3,069,000 |
| 2018-11-09 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 300,000 | 4.79 | 1,437,000 |
| 2018-11-09 | Johnson Kevin C | Sale | 66,007 | 17.05 | 1,125,089 |
| 2018-10-22 | Brodie Steven G. (VP - Pharma Operations) | Option Ex | 13,334 | 3.45 | 46,002 |
| 2018-08-01 | Jones Steven C (Executive Vice President) | Sale | 119,948 | 14.00 | 1,679,272 |
| 2018-07-31 | Jones Steven C (Executive Vice President) | Sale | 38,952 | 14.00 | 545,328 |
| 2018-07-30 | Jones Steven C (Executive Vice President) | Sale | 44,600 | 14.01 | 624,623 |
| 2018-06-29 | Shovlin Robert J. (President, Clinical Services) | Sale | 12,941 | 13.12 | 169,785 |
| 2018-06-22 | Jones Steven C (Executive Vice President) | Sale | 89,688 | 14.04 | 1,259,219 |
| 2018-06-19 | Jones Steven C (Executive Vice President) | Sale | 158,312 | 13.32 | 2,108,082 |
| 2018-06-15 | Jones Steven C (Executive Vice President) | Sale | 2,000 | 13.25 | 26,500 |
| 2018-06-01 | Jones Steven C (Executive Vice President) | Sale | 230,533 | 12.12 | 2,794,059 |
| 2018-05-31 | Jones Steven C (Executive Vice President) | Sale | 17,548 | 11.68 | 204,960 |
| 2018-05-30 | Jones Steven C (Executive Vice President) | Sale | 37,619 | 11.72 | 440,894 |
| 2018-05-29 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 65,000 | 11.66 | 757,900 |
| 2018-05-29 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 65,000 | 4.78 | 310,700 |
| 2018-05-29 | Jones Steven C (Executive Vice President) | Sale | 114,300 | 11.67 | 1,333,881 |
| 2018-05-25 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 6,666 | .00 | 0 |
| 2018-05-25 | Shovlin Robert J. (President, Clinical Services) | Option Ex | 16,666 | .00 | 0 |
| 2018-05-25 | Cardoza George (President, Pharma Services) | Option Ex | 8,333 | .00 | 0 |
| 2018-05-25 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 65,680 | .00 | 0 |
| 2018-05-15 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 13,000 | 11.23 | 146,055 |
| 2018-05-15 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 13,000 | 4.78 | 62,140 |
| 2018-05-10 | Ross Steven A (CIO) | Sale | 81,999 | 10.78 | 883,949 |
| 2018-05-10 | Ross Steven A (CIO) | Option Ex | 81,999 | 6.48 | 531,599 |
| 2018-03-28 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 7,000 | 4.78 | 33,460 |
| 2017-08-24 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 22,500 | 3.60 | 81,112 |
| 2017-08-09 | Hannah Alison L. (Director) | Option Ex | 6,667 | 6.66 | 44,402 |
| 2017-07-27 | Hannah Alison L. (Director) | Buy | 20,000 | 9.19 | 183,800 |
| 2017-07-05 | Brodie Steven G. (Vice President of Operations) | Option Ex | 6,666 | 3.45 | 22,997 |
| 2017-06-22 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 10,723 | 8.49 | 91,038 |
| 2017-06-05 | Ross Steven A (CIO) | Sale | 45,833 | 7.79 | 357,039 |
| 2017-06-02 | Ross Steven A (CIO) | Sale | 25,000 | 7.71 | 192,750 |
| 2017-06-02 | Ross Steven A (CIO) | Option Ex | 70,833 | 4.36 | 308,477 |
| 2017-05-30 | Hannah Alison L. (Director) | Option Ex | 7,222 | .00 | 0 |
| 2017-05-30 | Tetrault Lynn A. (Director) | Option Ex | 7,222 | .00 | 0 |
| 2017-05-30 | Robison William J (Director) | Option Ex | 7,222 | .00 | 0 |
| 2017-05-30 | Johnson Kevin C (Director) | Option Ex | 7,222 | .00 | 0 |
| 2017-05-30 | Crowther Bruce K (Director) | Option Ex | 7,222 | .00 | 0 |
| 2017-05-30 | Hipp Raymond R (Director) | Option Ex | 7,222 | .00 | 0 |
| 2017-05-26 | Balliet Jennifer (VP and Chief Culture Officer) | Sale | 3,334 | 7.50 | 25,005 |
| 2017-03-20 | Brodie Steven G. (President, Pharma Services) | Sale | 33,450 | 7.90 | 264,255 |
| 2017-03-13 | Brodie Steven G. (President, Pharma Services) | Sale | 33,100 | 8.00 | 264,800 |
| 2017-02-02 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 200,000 | 1.71 | 342,000 |
| 2017-01-03 | Johnson Kevin C (Director) | Option Ex | 3,333 | 4.78 | 15,931 |
| 2016-12-06 | Brodie Steven G. (President, Pharma Services) | Option Ex | 10,000 | 1.69 | 16,900 |
| 2016-10-07 | Balliet Jennifer (VP and Chief Culture Officer) | Option Ex | 3,334 | 1.10 | 3,667 |
| 2016-09-23 | Albitar Maher (Chief Medical Officer) | Sale | 2,800 | 8.40 | 23,520 |
| 2016-09-20 | Albitar Maher (Chief Medical Officer) | Sale | 105,300 | 8.20 | 863,459 |
| 2016-09-12 | Albitar Maher (Chief Medical Officer) | Sale | 51,000 | 8.21 | 418,710 |
| 2016-09-09 | Albitar Maher (Chief Medical Officer) | Sale | 9,075 | 8.31 | 75,413 |
| 2016-08-19 | Albitar Maher (Chief Medical Officer) | Sale | 370,000 | 8.23 | 3,045,100 |
| 2016-08-19 | Albitar Maher (Chief Medical Officer) | Option Ex | 570,000 | 2.77 | 1,580,610 |
| 2016-05-27 | Van Oort Douglas M (Chairman and CEO) | Sale | 383,000 | 8.74 | 3,347,420 |
| 2016-05-26 | Van Oort Douglas M (Chairman and CEO) | Sale | 98,387 | 8.69 | 854,983 |
| 2016-05-25 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 600,000 | 1.71 | 1,026,000 |
| 2016-05-18 | Ross Steven A (CIO) | Sale | 18,000 | 8.50 | 153,000 |
| 2016-05-18 | Ross Steven A (CIO) | Option Ex | 18,000 | 4.78 | 86,040 |
| 2016-05-09 | Ross Steven A (CIO) | Sale | 15,000 | 8.22 | 123,300 |
| 2016-05-09 | Ross Steven A (CIO) | Option Ex | 15,000 | 4.78 | 71,700 |
| 2016-05-02 | Jones Steven C (Executive VP of Finance) | Sale | 177,745 | 8.21 | 1,459,286 |
| 2016-04-29 | Balliet Jennifer (VP of Human Resources) | Option Ex | 3,334 | 1.45 | 4,834 |
| 2016-04-29 | Ross Steven A (CIO) | Sale | 112,500 | 8.11 | 912,374 |
| 2016-04-29 | Ross Steven A (CIO) | Option Ex | 112,500 | 3.93 | 442,125 |
| 2016-03-11 | Cardoza George (Chief Financial Officer) | Sale | 32,000 | 6.83 | 218,560 |
| 2016-03-11 | Cardoza George (Chief Financial Officer) | Option Ex | 100,000 | 1.46 | 146,000 |
| 2016-03-10 | Brodie Steven G. (Chief Scientific Officer) | Option Ex | 50,000 | 1.48 | 74,000 |
| 2016-03-09 | Van Oort Douglas M (Chairman and CEO) | Sale | 160,000 | 6.93 | 1,108,800 |
| 2016-03-08 | Van Oort Douglas M (Chairman and CEO) | Sale | 290,000 | 7.19 | 2,085,100 |
| 2016-03-08 | Van Oort Douglas M (Chairman and CEO) | Option Ex | 1,000,000 | .80 | 800,000 |
| 2016-03-04 | Johnson Kevin C (Director) | Buy | 7,207 | 6.84 | 49,295 |
| 2016-03-03 | Johnson Kevin C (Director) | Buy | 14,800 | 6.75 | 99,900 |
| 2015-12-29 | Horel Robert H. (Vice President GM PathLogic) | Option Ex | 51,218 | 1.57 | 80,412 |
| 2015-12-21 | Tetrault Lynn A. (Director) | Buy | 9,500 | 8.21 | 77,995 |
| 2015-12-07 | Tetrault Lynn A. (Director) | Buy | 3,500 | 7.72 | 27,020 |
| 2015-12-03 | Shovlin Robert J. (Chief Operating Officer) | Buy | 6,550 | 7.75 | 50,762 |
| 2015-11-27 | Aspen Select Healthcare Lp (10% Owner) | Sale | 35,000 | 8.06 | 282,065 |
| 2015-11-25 | Aspen Select Healthcare Lp (10% Owner) | Sale | 350,000 | 8.10 | 2,833,250 |
| 2015-11-02 | Crowther Bruce K (Director) | Buy | 6,400 | 7.81 | 49,977 |
Insider trading activities including stock purchases, stock sales, and option exercises of NEO listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Neogenomics Inc (symbol NEO, CIK number 1077183) see the Securities and Exchange Commission (SEC) website.